Abstract
A method or use related to administering an anti-B7H3 antibody-drug conjugate in combination with another therapeutic agent to treat cancer; said other therapeutic agent is selected from anti-PD-L1 antibody or antigen-binding fragment thereof or/and a chemotherapy drug. The present invention further relates to the use of a drug composition and a drug kit in the treatment of cancer.
Full Text
What is claimed is:
A method or use related to administering an anti-B7H3 antibody-drug conjugate in combination with another therapeutic agent to treat cancer; said other therapeutic agent is selected from anti-PD-L1 antibody or antigen-binding fragment thereof or/and a chemotherapy drug. The present invention further relates to the use of a drug composition and a drug kit in the treatment of cancer.
Timeline
Filed
05/13/2026Published
09/03/2026Granted
Not AvailableIPC Codes(6)
A61K 47/68:the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 39/00:Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53)